S. 1041 is a bill that aims to update U.S. patent laws regarding biological products to address patent infringement issues. It allows the sponsor of a biologic drug reference product to sue an applicant for a similar product for infringement on a limited number of patents,...
Simple Explanation
S. 1041 is a bill that wants to change some rules about biological medicines so that people who make them can protect their ideas but still let others try to make similar medicines in a fair way.